Product
Expansion Cohort
1 clinical trial
1 indication
Indication
MesotheliomaClinical trial
Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural MesotheliomaStatus: Recruiting, Estimated PCD: 2023-08-31
1 clinical trial
1 indication